2016, Número 618
<< Anterior Siguiente >>
Rev Med Cos Cen 2016; 73 (618)
Coriorretinopatía central serosa
Abarca A
Idioma: Español
Referencias bibliográficas: 12
Paginas: 113-117
Archivo PDF: 163.42 Kb.
RESUMEN
Casi el 10% de las consultas de
emergencia se deben a dolor
abdominal agudo. En las personas
mayores de 65 años, puede tener
presentaciones atípicas, que
retardan el diagnóstico correcto y
empeora el pronóstico.
REFERENCIAS (EN ESTE ARTÍCULO)
Bousquet, E., Beydoun, T., Rothschild, P., Bergin, C., Zhao, M., Batista, R., et al. (2015). Spironolactone for Nonresolving Central Serous Chorioretinopathy. Journal of Retineal and Vitreous Diseases , 1-11.
Hata, M., Oishi, A., Shimozono, M., Mandai, M., Nishida, A., & Kurimoto, Y. (2013). Early Changes in Foveal Thickness in Eyes with Central Serous Chorioretinopathy. Journal of Retineal and Vitreous Diseases , 296-301.
Kim, D., Joe, S., Yang, H., Lee, J., Kim, J., & Yoon, Y. (2014). Subfoveal Choroidal Tickness Changes in Treated Idiopathic Central Serous Chorioretinopathy and their Association with Recurrence . Journal of Retineal and Vitreous Diseases, 1867-1874.
Liu, D., Fok, A., & Lam, D. (2012). An Update on the Diagnosis and Management of Central Serous Chorioretinopathy. Asia-Pacific Journal of Ophtalmology , 296-302.
Malik, K., Sampat, K., Mansouri, A., Steiner, J., & Glaser, B. (2015). Low- Intensity/High Density Subthreshold Micropulse Diode Laser for Chronic Central Serous Chorioretinopathy. Journal of Retineal and Vitreous Diseases, 532-536.
6-Peiretti, E., Ferrara, D., Caminiti, G., Mura, M., & Hughes, J. (2015). Choroidal Neovascularization in Caucasian Patients with Longstanding Central Serous Chorioretinopathy. Journal of Retinal and Vitreous Diseases , 1360-1367.
Prakash, G., Chauhan, N., Jain, S., & Satsangi, K. (2013). Central Serous Chorioretinopathy: a Review of Literature. Asia-Pacific Journal of Ophthalmology , 104-110.
Ross, A., Ross, A., & Mohamed, Q. (2011). Review and Update of Central Serous Chorioretinopathy. Current Opinion in Ophthalmology, 166-173.
Shiode, Y., Morizane, Y., Kimura, S., Hosokawa, M., Kawata, T., Doi, S., et al. (2015). Comparison of Halving the Irradiation Time or the Verteporfin Dose in Photodynamic Therapy for Chronic Central Serous Chorioretinopathy. Journal of Retinal and Vitreous Diseases, 1-7.
Siddique, S., & Foster, S. (2010). Central Serous Chorioretinopathy. Contemporary Ophthalmology, 1-8.
Wu, Z., Lai, R., Yip, Y., Chan, W., Lam, D., & Lai, T. (2011). Improvement in Multifocal Electroretinography after Halfdose Verteporfin Photodynamic Therapy for Central Serous Chorioretinopathy. Journal of Retinal and Vitreous Diseases , 1-9.
Yalcinbayir, O., Gelisken, O., Akova-Budak, V., Ozkaya, G., Cevik, S., & Yucel, A. (2014). Correlation of Spectral Domain Optical Coherence Tomography Findings and Visual Acuity in Central Serous Chorioretinopathy. Journal of Retinal and Vitreous Diseases , 705-713.